Table 2: Survival outcome according to different prognostic factors.
Variables | 5-Y OS | 5-Y PFS | |
Age | < 60 | 57.2% | 43.7% |
≥ 60 | 63.2% | 37.6% | |
P = 0.3 | P = 0.3 | ||
Sex | M | 60.8% | 43.0% |
F | 54.4% | 35.9% | |
P = 0.71 | P = 0.36 | ||
ECOG PS | < 2 | 68.8% | 49.7% |
≥ 2 | 41.6% | 23.4% | |
P = 0.007 | P = 0.028 | ||
Tobacco | Yes | 60.7% | 33.7% |
NO | 53.1% | 40.8% | |
N/A | 60.5% | 53.2% | |
P = 0.75 | P = 0.96 | ||
LN status | Negative | 77.8% | 65.5% |
Positive | 35.6% | 17.7% | |
P = 0.0009 | P = 0.0005 | ||
T-stage | T1-T2 | 66.6% | 51% |
T3-T4 | 48.2% | 30.6% | |
P = 0.09 | P = 0.22 | ||
Stage Group | Early (I/II) | 77.1% | 65.6% |
Advanced (III/IV) | 45.9% | 28.1% | |
P = 0.028 | P = 0.02 |
Ecog: Eastern Cooperative Oncology Group; Ps: Performance Status; Ln: Lymph Nodes.